✦ LIBER ✦

266 POSTER Preclinical evaluation of IL-21 combination therapy with sorafenib and sunitinib in renal cell carcinoma

✍ Scribed by P.V. Sivakumar; B. Johnson; K. Brasel; M. Anderson; S. Hughes; C. Clegg; D.M. Miller; A. Hey; P.E.G. Kristjansen; M. Kragh

Book ID: 118623894
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 58 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70271-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

408 POSTER Phase 1 study of recombinant

408 POSTER Phase 1 study of recombinant human Interleukin-21 (rIL-21) in combination with sunitinib in patients with stage IV renal cell carcinoma

✍ V. Grünwald; I. Desar; J. Haanen; W. Fiedler; M.B. Olsen; C.M.L. van Herpen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

204 POSTER Recombinant IL-21 in combinat

204 POSTER Recombinant IL-21 in combination with sorafenib as second or third-line therapy for metastatic renal cell carcinoma (mRCC): Interim results from a Phase 2 study

✍ T.W. Flaig; B.D. Curti; M.S. Gordon; P.J. Van Veldhuizen; W.H. Miller; M.S. Erns 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Third-line sunitinib following sequentia

Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinoma

✍ Hideaki Miyake,Yuji Kusuda,Ken-ichi Harada… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 230 KB

Antitumor Effects of Sunitinib or Sorafe

Antitumor Effects of Sunitinib or Sorafenib in Patients With Metastatic Renal Cell Carcinoma Who Received Prior Antiangiogenic Therapy

✍ Tamaskar, Ila; Garcia, Jorge A.; Elson, Paul; Wood, Laura; Mekhail, Tarek; Dreic 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 355 KB

437 POSTER In vivo evaluation of sorafen

437 POSTER In vivo evaluation of sorafenib (Nexavar®) and sunitinib (Sutent®) alone and in combination with Rapamycin in two human renal tumor xenograft models

✍ M. Wick; F. Roldan; S. Kelly; W. Lowell; L. Gomez; J. Esquivel; J. Marty; C. Tak 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

PCN5 PHARMACOECONOMIC ANALYSIS OF SORAFE

PCN5 PHARMACOECONOMIC ANALYSIS OF SORAFENIB AND SUNITINIB FOR FIRST LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) COMPARED WITH COMBINATION THERAPY OF BEVACIZUMAB, GEMCITABINE, AND CAPECITABINE (BGC) AT A LARGE CANCER CENTER

✍ WD Smith; R Arbuckle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB